Intelligence Β· Clinical Pipeline

Ningbo Cancer Hospital Pipeline

All ClinicalTrials.gov programs at Ningbo Cancer Hospital β€” phase, modality, and trial IDs.

Programs
1

Quick answer

Ningbo Cancer Hospital has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Phase Ib of Cyclophosphamide, Pomalidomide, Dexamethasone and Daratumumab (CPD-DARA) in patients with relapsed/refractory multiple myeloma. (The CPD-DARA Study).

    Ningbo Cancer Hospital

    Relapsed/ refractory multiple myeloma

    phase 1 other active

    1 trial

Frequently asked questions

How many pipeline programs does Ningbo Cancer Hospital have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs